Atsuki Fukushima Selected Research

Allergic Conjunctivitis (Giant Papillary Conjunctivitis)

7/2020	Japanese guidelines for allergic conjunctival diseases 2020.
12/2019	Air pollution significantly associated with severe ocular allergic inflammatory diseases.
4/2019	Periostin deletion suppresses late-phase response in mouse experimental allergic conjunctivitis.
1/2019	In vitro and in vivo performance of epinastine hydrochloride-releasing contact lenses.
11/2018	Oral Immunotherapy for Allergic Conjunctivitis Using Transgenic Rice Expressing Hypoallergenic Antigens.
1/2018	Efficacy of oral immunotherapy with a rice-based edible vaccine containing hypoallergenic Japanese cedar pollen allergens for treatment of established allergic conjunctivitis in mice.
4/2017	Japanese guidelines for allergic conjunctival diseases 2017.
2/2016	One-year clinical evaluation of 0.4% ripasudil (K-115) in patients with open-angle glaucoma and ocular hypertension.
8/2015	Roles of Epithelial Cell-Derived Type 2-Initiating Cytokines in Experimental Allergic Conjunctivitis.
5/2015	Prevention of allergic conjunctivitis in mice by a rice-based edible vaccine containing modified Japanese cedar pollen allergens.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsuki Fukushima Research Topics

Disease

47	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 07/2020 - 02/2002
11	Conjunctivitis 06/2022 - 10/2003
10	Hypersensitivity (Allergy) 06/2022 - 02/2005
10	Hyperemia 01/2020 - 07/2009
9	Conjunctival Diseases 07/2020 - 11/2004
9	Inflammation (Inflammations) 12/2017 - 11/2002
7	Glaucoma 11/2020 - 08/2003
4	Neoplasms (Cancer) 06/2022 - 06/2007
4	Retinal Detachment (Retinal Detachments) 05/2022 - 06/2019
4	Bacterial Infections (Bacterial Infection) 08/2017 - 09/2011
4	Uveitis 07/2014 - 05/2003
3	Atrophy 05/2022 - 01/2012
3	Necrosis 05/2022 - 07/2013
3	Keratoconjunctivitis 03/2020 - 01/2004
3	Infections 11/2019 - 06/2011
3	Keratitis 08/2017 - 01/2012
3	Pruritus (Itching) 10/2014 - 09/2006
3	Eosinophilia 08/2013 - 04/2011
2	Asthma (Bronchial Asthma) 06/2022 - 01/2008
2	Exfoliation Syndrome 03/2022 - 02/2016
2	Endophthalmitis (Ophthalmia) 01/2021 - 11/2019
2	Atopic Dermatitis (Atopic Eczema) 07/2019 - 01/2019
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2019 - 02/2016
2	Blepharitis 01/2019 - 02/2016
2	Ocular Hypertension (Glaucoma, Suspect) 01/2019 - 02/2016
2	Dry Eye Syndromes (Dry Eye Syndrome) 12/2014 - 07/2013
2	Immediate Hypersensitivity 07/2013 - 02/2009
2	Retinitis 01/2013 - 07/2003
1	Headache (Headaches) 08/2022
1	Optic Nerve Diseases (Optic Neuropathy) 08/2022
1	Sinusitis 06/2022
1	Immunoglobulin G4-Related Disease 06/2022
1	Prostatic Neoplasms (Prostate Cancer) 05/2022
1	Birdshot Chorioretinopathy 05/2022
1	Retinal Hemorrhage 07/2021
1	Communicable Diseases (Infectious Diseases) 01/2021

Drug/Important Bio-Agent (IBA)

22	Ophthalmic Solutions (Eye Drops)IBA 06/2022 - 05/2006
13	AntigensIBA 11/2018 - 02/2002
13	CytokinesIBA 12/2017 - 11/2004
8	SteroidsIBA 11/2020 - 08/2003
8	Pharmaceutical PreparationsIBA 07/2020 - 04/2009
7	AllergensIBA 01/2018 - 04/2005
6	Tacrolimus (Prograf)FDA LinkGeneric 11/2020 - 04/2010
6	Anti-Allergic Agents (Antiallergic Agents)IBA 07/2020 - 04/2010
5	Retinaldehyde (Retinal)IBA 05/2022 - 11/2002
5	K-115IBA 01/2020 - 02/2016
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2005
5	Immunoglobulin E (IgE)IBA 05/2012 - 04/2005
4	AntibodiesIBA 06/2022 - 02/2007
4	SuspensionsIBA 01/2019 - 06/2009
4	rho-Associated KinasesIBA 01/2019 - 02/2016
4	MucinsIBA 12/2014 - 02/2007
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2014 - 05/2006
3	Bimatoprost (Lumigan)FDA Link 03/2016 - 01/2012
3	InterleukinsIBA 08/2015 - 02/2005
3	LigandsIBA 12/2008 - 02/2007
3	Platelet Activating FactorIBA 10/2006 - 09/2004
2	Vancomycin FDA LinkGeneric 01/2021 - 11/2019
2	dupilumabIBA 03/2020 - 07/2019
2	Therapeutic UsesIBA 11/2019 - 01/2012
2	epinastine FDA Link 01/2019 - 10/2014
2	Antiviral Agents (Antivirals)IBA 01/2018 - 01/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 08/2003
2	VaccinesIBA 01/2018 - 05/2015
2	Interleukin-33IBA 12/2017 - 08/2015
2	LipopolysaccharidesIBA 08/2017 - 01/2016
2	Fluorometholone (FML)FDA Link 01/2017 - 06/2009
2	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 03/2016 - 02/2016
2	Peptides (Polypeptides)IBA 01/2016 - 07/2014
2	rebamipideIBA 12/2014 - 07/2013
2	Messenger RNA (mRNA)IBA 12/2014 - 07/2014
2	SecretagoguesIBA 12/2014 - 07/2013
2	OvalbuminIBA 11/2014 - 11/2013
2	Histamine (Histamine Dihydrochloride)FDA Link 11/2013 - 07/2009
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 08/2013 - 09/2011
2	Chemokine CCL11IBA 08/2013 - 02/2009
2	HCEIBA 08/2013 - 07/2013
2	aluminum sulfate (alum)IBA 04/2011 - 08/2008
2	alpha-galactosylceramideIBA 09/2008 - 09/2006
2	InterferonsIBA 06/2007 - 01/2005
1	GadoliniumIBA 08/2022
1	Biological ProductsIBA 06/2022
1	Cytokine Receptors (Cytokine Receptor)IBA 06/2022
1	Silicone OilsIBA 05/2022
1	Dinoprostone (PGE2)FDA Link 01/2020
1	omidenepag isopropylIBA 01/2020
1	Air Pollutants (Pollutants, Air)IBA 12/2019
1	Peroxidase (Myeloperoxidase)IBA 11/2019
1	PeriostinIBA 04/2019
1	Protein Kinase InhibitorsIBA 01/2019

Therapy/Procedure

8	Therapeutics 01/2021 - 01/2008
4	Immunotherapy 11/2018 - 11/2014
3	Slit Lamp 01/2020 - 01/2017
3	Oral Administration 11/2018 - 04/2013
2	Vitrectomy 05/2022 - 11/2002
2	Phage Therapy 01/2021 - 11/2019
1	Trabeculectomy (Trabeculoplasty) 03/2022
1	Intraocular Lenses (Intraocular Lens) 03/2022
1	Drug Therapy (Chemotherapy) 06/2019
1	Hydrophilic Contact Lenses (Hydrophilic Contact Lens) 01/2019